OpenAI acquires Orchestra Bio
Primary sourceOpenAI
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
Also carried by The Decoder, SiliconANGLE, Asianet Newsable, Zee Business and 8 more.
This notice was published by OpenAI. What you see here is a brief excerpt. The full text is theirs.
Continue reading at OpenAI





